Manufacturing of Controlled Substances lawyer New Jersey, NJ

Federal manufacturing of controlled substances charges under 21 U.S.C. § 841 carry distinct risks, including mandatory minimum sentences and the absence of parole in the federal system. When the U.S. Attorney’s Office for the District of New Jersey brings an indictment—often following a DEA or multi‑agency investigation—the proceedings follow federal procedural rules and sentencing guidelines that differ in fundamental ways from state‑court practice. For people facing an investigation, arrest, or grand jury subpoena in connection with an alleged drug manufacturing operation, early engagement with an attorney familiar with federal criminal defense can shape the direction of the case. Mr. Sris and the firm’s Of Counsel attorneys represent clients in federal manufacturing matters throughout New Jersey, from pre‑indictment proceedings to trial. To request a consultation, contact Law Offices Of SRIS, P.C. at (888) 437‑7747. Law Offices Of SRIS, P.C. – Advocacy Without Borders.

On this page

What Manufacturing of Controlled Substances Charges Mean in New Jersey

The U.S. Attorney’s Office prosecutes federal drug crimes—including manufacturing offenses—in the District of New Jersey, which maintains courthouses in Newark, Trenton, and Camden. An indictment under 21 U.S.C. § 841 may arise from an investigation conducted by the DEA, FBI, IRS‑CI, Homeland Security Investigations, or other federal task forces. Because the case originates in federal court, the Speedy Trial Act, the Federal Rules of Criminal Procedure, and the U.S. Sentencing Guidelines shape each stage of the proceeding, from initial appearance through sentencing.

Unlike many state drug charges, federal manufacturing offenses typically carry mandatory minimum terms of imprisonment that turn on the type and quantity of the controlled substance. The sentencing court also has discretion to impose fines, order restitution, and require asset forfeiture. Individuals facing these charges in New Jersey are subject to the same federal statutory framework as defendants in any other federal district, but local practice—such as the approach of the U.S. Attorney’s Office in Newark, case management by federal magistrate judges, and the Pretrial Services detention recommendation process—can influence the practical trajectory of a case. Law Offices Of SRIS, P.C. represents clients at the District of New Jersey and understands the procedures that govern federal criminal litigation in this region.

How Mr. Sris and the Firm’s Of Counsel Attorneys Handle Federal Manufacturing Cases

When a client retains the firm on a federal manufacturing matter, the representation begins with a thorough assessment of the investigation and charges. The legal team reviews discovery materials, identifies potential challenges to the government’s evidence—including the lawfulness of searches, the handling of forensic drug analysis, and the reliability of cooperating witnesses—and evaluates whether any pretrial motions could constrain the prosecution’s case. In many federal drug matters, the period before indictment offers opportunities to engage with the assigned Assistant U.S. Attorney and present information that may influence whether charges are brought and, if so, the specific charges included in the indictment.

Should the case proceed to prosecution, the firm prepares for each phase of the proceeding: detention hearing, arraignment, pretrial motions, possible plea negotiations, and trial if warranted. Throughout the process, Mr. Sris and the firm’s Of Counsel attorneys explain the implications of the U.S. Sentencing Guidelines, the potential for safety‑valve relief under 18 U.S.C. § 3553(f) when applicable, and the availability of substantial‑assistance departures. The goal is to ensure that the client understands the options at each juncture and can make informed decisions about how to proceed.

About Mr. Sris and the Firm’s Of Counsel Attorneys

Mr. Sris, Owner and Founder of Law Offices Of SRIS, P.C., is a former prosecutor who has concentrated his practice on criminal defense since founding the firm in 1997. He is admitted to practice in New Jersey, New York, Virginia, Maryland, and the District of Columbia, and he appears regularly in federal courts across those jurisdictions. Mr. Sris testified before the Virginia House Courts of Justice Committee in support of 2019 HB 635 (chief patron Del. David Bulova). His background as a former prosecutor informs his approach to federal drug manufacturing defense, including the evaluation of evidence from federal agencies and the negotiation of pretrial resolutions.

The firm’s Of Counsel attorneys bring experience across federal criminal matters and work alongside Mr. Sris on complex federal cases. Together, the team handles every stage of a federal manufacturing charge, from investigation through sentencing and, when appropriate, appeal. The firm maintains a New Jersey location in Tinton Falls and represents clients in all 21 New Jersey counties, including those whose cases arise in the Newark, Trenton, and Camden vicinages.

Frequently Asked Questions

Do I need a federal criminal defense lawyer if I am under investigation for manufacturing a controlled substance in New Jersey?

Yes, obtaining legal representation early—before an indictment is returned—can substantially affect the direction of a federal manufacturing investigation. Federal agents may interview witnesses, execute search warrants, and issue grand jury subpoenas before charges are filed. At that stage, an attorney can engage with the U.S. Attorney’s Office, attempt to clarify the scope of the investigation, and work to present mitigating information. Early involvement also helps protect the right against self‑incrimination and ensures that statements made to investigators do not inadvertently strengthen the government’s case.

What statute covers federal manufacturing of controlled substances?

The principal federal statute is 21 U.S.C. § 841, which makes it unlawful to manufacture, distribute, dispense, or possess with intent to manufacture, distribute, or dispense a controlled substance. The statute carries different mandatory minimum sentences depending on the type and quantity of the substance involved. For example, manufacturing certain amounts of cocaine, heroin, methamphetamine, or fentanyl can trigger a 5‑year or 10‑year mandatory minimum period of imprisonment. The prosecution must prove each element beyond a reasonable doubt, and the defense has the right to challenge the sufficiency of the evidence, laboratory results, and the chain of custody.

How does a federal drug manufacturing case move through the District of New Jersey?

The process generally begins with an investigation, followed by a grand jury indictment, an initial appearance before a federal magistrate judge, a detention hearing, pretrial discovery, motions, potential plea negotiations, and, if no resolution is reached, a jury trial. After a plea or verdict, the U.S. Probation Office prepares a presentence report, and the court imposes a sentence guided by the U.S. Sentencing Guidelines. Because federal sentences for manufacturing offenses often involve mandatory minimums and there is no parole, the choices made during pretrial proceedings can have lasting consequences. Contacting an attorney early—ideally before indictment—provides an opportunity to influence the course of the case.

What viable defenses exist in federal manufacturing cases?

Defenses commonly explored in federal manufacturing prosecutions include challenging the legality of the search and seizure, contesting the government’s ability to prove knowing or intentional conduct, and attacking the reliability of forensic drug analysis or cooperating‑witness testimony. In some cases, the defense may argue that the defendant’s involvement was limited and did not meet the statutory definition of manufacturing, or that the substance in question is not a controlled substance under the relevant schedule. Additionally, challenges to the chain of custody or the validity of a warrant can lead to suppression of key evidence. Each defense turns on the specific facts and the thorough investigation of the government’s case.

Can a federal manufacturing charge be reduced or dismissed before trial?

Yes, a federal manufacturing charge can be reduced or dismissed before trial through pretrial motions, negotiations with the U.S. Attorney’s Office, or the presentation of exculpatory evidence. For example, a motion to suppress evidence obtained through an unlawful search may effectively eliminate the prosecution’s proof, experienced to dismissal. In other situations, the government may agree to a plea to a lesser included offense if the defense can show weaknesses in the case or demonstrate that the defendant played a minor role. The outcome depends on the evidence, the procedural posture, and the skill of the defense team in identifying and advocating for a favorable resolution.

How long does a federal criminal case typically take in New Jersey?

The duration of a federal criminal case varies based on its complexity, the number of defendants, and pretrial motions, but many manufacturing cases resolve within several months to over a year. The Speedy Trial Act imposes time limits on the government, yet complex drug‑manufacturing investigations often involve extensive discovery and expert witnesses, which can extend the schedule. A case that proceeds to trial may take longer than one that resolves through a plea. The court’s calendar and the posture of the case also influence the timeline.

Last reviewed: July 2026
Reviewed by Mr. Sris, Owner and Founder. Admitted in Virginia, Maryland, the District of Columbia, New Jersey, and New York. Practicing since 1997.

Official sources:
21 U.S.C. § 841 – Federal drug manufacturing statute
U.S. District Court for the District of New Jersey
U.S. Attorney’s Office – District of New Jersey

Attorney advertising. Prior results do not guarantee a similar outcome.
Attorney responsible for this advertising: Mr. Sris.
Results may vary.

Case results depend on a variety of factors unique to each case.